Initial evidence also suggests a role for BCAR1 in prostate cancer progression, as its overexpression was linked to an unfavorable tumor phenotype and biochemical relapse in three studies analyzing 110 [4], 130 [5] and 242 [6] prostate cancer specimens. This evidence concerns the gene BCAR1 and Familial prostate cancer.